LAUNCHES, PROMOTIONS, MERCHANDISING, EVENTS AND OTHER THINGS TO KEEP YOU IN THE KNOW.
Johnson & Johnson Vision to Acquire TearScience
Johnson & Johnson Vision announced a definitive agreement to acquire TearScience, Inc., which manufactures medical devices, including LipiFlow and LipiFlow Activator II (pictured), for evaluating meibomian gland health and treating meibomian gland dysfunction. Johnson & Johnson Vision will acquire TearScience through its surgical vision operating company, Abbott Medical Optics Inc. The transaction is expected to close by the end of the year. For more information, visit JNJVC.com and TearScience.com.
Eyes of America Seminar Offers Eight Hours of CE
Primary Eyecare Network (PEN), a division of ABB OPTICAL GROUP, will present its annual Eyes of America Fall Seminar on Sunday, Sept. 24, 8am to 5pm in Columbus, OH. Participants can earn up to eight hours of optometric continuing education credits while learning about topics such as glaucoma surgery, glaucoma pharmaceuticals, ocular triage and pediatric eyecare. The cost is $170 for the morning session, $145 for the afternoon session or $250 for the full day. For more information or to register, visit EyesOfAmerica.org or call 800.444.9230.
MacuLogix, Inc., has formed a new Optometric Advisory Board led by MacuLogix co-founder and chief technology officer Greg Jackson, PhD, and has named these seven optometrists as clinical advisors: Glenn S. Corbin, Steven G. Ferrucci, Jeffry D. Gerson, Paul M. Karpecki, Gary S. Kirman, Pamela Lowe and Laurie Sorrenson.
Shire plc has submitted a Marketing Authorization Application for lifitegrast, its lymphocyte function-associated antigen-1 (LFA-1) antagonist used to treat dry eye signs and symptoms, in Europe.
HOYA Corp. has completed the acquisition of Performance Optics, LLC, including its subsidiaries, VISION EASE and Daemyung Optical.